EUVIMEDEUVIMED entdecken
Crossref

Risk of reoperation following rheumatic mitral repair: Long-term longitudinal analysis

Masafumi Shibata, Kitae Kim, Yoshikazu Ono, Hong Rae Kim, Ho Jin Kim, Jae Suk Yoo, Sung-Ho Jung, Jae Won Lee, Joon Bum Kim

The Journal of Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1016/j.jtcvs.2025.09.049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Masafumi Shibata und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, Calif. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Reoperation, Mitral Valve, Mitral Valve Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Asan Institute for Life Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To evaluate long-term outcomes of rheumatic mitral valve (MV) repair and identify the risk factors of MV reoperation. METHODS: This retrospective, single-center cohort study evaluated 337 patients who underwent MV repair for rheumatic disease between 2000 and 2022. The primary outcome was MV reoperation. Competing risk analyses using Fine-Gray models were performed, with death as the competing risk. RESULTS: MV repair techniques included ring annuloplasty (81.0%), commissure procedures (33.5%), leaflet resection (2.7%), posterior mitral leaflet mobilization (14.8%), anterior mitral leaflet (AMVL) augmentation (4.2%), Alfieri procedure (2.7%), papillary muscle splitting (12.8%), and chordal procedures (30.6%). The 30-day mortality rate was 0.9%. Over a median follow-up of 15.2 years (interquartile range, 7.7-19.4 years; total, 4629.71 patient-years), 54 patients died, with a 20-year survival of 78.9% (95% CI, 73.6%-84.5%). Thirty-two patients required MV reoperation for regurgitation (n = 15), mitral stenosis (MS) (n = 14), and mixed lesions (n = 3). The cumulative risk of reoperation was 4.5% at 10 years and 12.7% at 20 years. Independent risk factors included tricuspid regurgitation velocity >3.4 m/s (hazard ratio [HR], 3.26; P = .005), moderate-to-severe MS (HR, 4.39; P < .001), AMVL augmentation (HR, 5.84; P = .001), and chordal procedures (HR, 2.99; P = .004). The 20-year reoperation rates were 1.0%, 12.7%, and 33.6% in patients with 0, 1, and ≥2 risk factors, respectively (P < .001). CONCLUSIONS: The long-term durability of rheumatic MV repair is significantly affected by such risk factors as pulmonary hypertension, moderate-to-severe MS, AMVL augmentation, and chordal procedures. Repair is preferable in patients without these risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic Heart DiseaseReoperationMitral ValveMitral Valve InsufficiencyMitral Valve AnnuloplastyPostoperative ComplicationsHeart Valve Prosthesis ImplantationHumansMaleFemaleRetrospective StudiesMiddle AgedRisk FactorsAdultTime FactorsRisk AssessmentTreatment OutcomeAgedLongitudinal Studies

Stichwörter der Autor:innen

Five-Gray competing risk modellong-term outcomesmitral valve repairreoperationrheumatic heart disease

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, Calif.
  • Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Department of Thoracic and Cardiovascular Surgery, Armed Forced Military Hospital, Bundang, South Korea.
  • Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: jbkim1975@amc.seoul.kr.

Förderung

  • Asan Institute for Life Sciences

Zitieren

APA

Shibata, M., Kim, K., Ono, Y., Kim, H. R., Kim, H. J., Yoo, J. S., Jung, S. H., Lee, J. W., & Kim, J. B. (2025). Risk of reoperation following rheumatic mitral repair: Long-term longitudinal analysis. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.09.049

Vancouver

Shibata M, Kim K, Ono Y, Kim HR, Kim HJ, Yoo JS, et al. Risk of reoperation following rheumatic mitral repair: Long-term longitudinal analysis. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2025.09.049

BibTeX
@article{Shibata2025,
  author = {Shibata, Masafumi and Kim, Kitae and Ono, Yoshikazu and Kim, Hong Rae and Kim, Ho Jin and Yoo, Jae Suk and Jung, Sung-Ho and Lee, Jae Won and Kim, Joon Bum},
  title = {Risk of reoperation following rheumatic mitral repair: Long-term longitudinal analysis},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1016/j.jtcvs.2025.09.049}
}
Kostenlos starten →